~," Fourteen cases of primary intracranial germ-cell tumors are presented. Histologically, there were eight germinomas, three teratomas, and three germ-cell tumors of more than one histological type. Immunohistochemical studies revealed alpha-fetoprotein in yolk-sac tumor components in two cases and beta human choriogonadotropin in syncytiotrophoblastic giant cells in one case. One teratoma contained an unusual pleomorphic sarcomatous portion with features of early myoblastic differentiation. Comparison of intracranial with gonadal germ-cell tumors shows that the same subtypes are found in both locations with comparable incidence and similar biological behavior. The detailed World Health Organization classification of testicular germ-cell tumors should be applied to the histopathological classification of intracranial germ-cell tumors. Despite the critical location of intracranial germ-cell tumors, a good outcome can be achieved by optimal surgical excision. A primary microsurgical approach provides a histopathological diagnosis, which is indispensable for the proper choice of postoperative management.
T

HE World Health Organization classification of
intracranial germ-cell tumors 32 is based on the much more detailed classification of testicular tumors. ~4 However, it has not been established if the subtypes described for the testicular location are found with the same relative incidence intracranially and if they show the same biological behavior. These questions can only be answered when a direct surgical approach is used. There is a controversy about management of these tumors between proponents of primary surgical excision ~~ and supporters of conservative therapy, including ventricular shunting and radiotherapy.l. 12, 21 We report here our experience with primary direct microsurgical techniques for removal of tumors in the pineal region to support increasing evidence of the benefits of this approach.~~
Summary of Cases
This series included eight patients with pure germinomas, three with teratomas, and three with mixed germ-cell tumors. The clinical data, including the patient's age and sex, main clinical symptoms, site of tumor, pre-and postoperative treatment (shunting, radiotherapy, chemotherapy), operative procedure, recurrences, survival time, and histopathological diagnosis, are given in Tables 1 and 2 . Typical pre-and postoperative computerized tomography scans are presented from Cases 1 2 and 1 4 in Figs. 1 and 2 .
From a histopathological point of view, two cases were of special interest. In Case 9, immunohistochemical staining revealed alpha-fetoprotein (AFP) in the yolk-sac component (Fig. 3 left) , and syncytiotrophoblastic giant cells were found within the germinoma component. These giant cells stained positive for betahuman choriogonadotropin (HCG, Fig. 3 right) . The second patient (Case 12) had an immature teratoma. In addition to the glandular structures, the tumor contained areas of haphazardly arranged spindle-shaped malignant cells (Fig. 4 left) that stained positive with phosphotungstic acid hematoxylin (PTAH); no definite cross striations were evident (Fig. 4 right) .
Discussion
The incidence of primary intracranial germ-cell tumors is about 0.5% in adults and 2% in children, 23' 3~ reaching higher values of up to 4% in Japan. 3'9 Our 14 cases represent 0.7% of the intracranial neoplasms seen in the last 8 years at our institution.
Age at diagnosis ranged from 7 to 50 years with a mean of 16 years, corresponding to the figures given in the literature. 4-6 The remarkable finding that all our patients with teratomas and/or mixed germ-cell tumors were males confirms the well known preponderance of male patients with this disease, z'7,~'16 In the last few years, serological screening for germ-cell tumor markers, such as AFP and beta-HCG, has been used increasingly. 17'23'26 Some authors have even concluded that an accurate diagnosis of intracranial germ-cell tumors is possible by determination of serum levels of AFP and beta-HCG alone, without the necessity for a biopsy. 7,~s This would speak in favor of conservative therapy with shunting and radiotherapy, as is proposed by several authors. 1'~2'2~ We think, however, that a definite diagnosis, on which further therapeutic management is to be based, can be achieved only by histological examination of the tumor, including the immunohistochemical demonstration of tumor cell components producing AFP and beta-HCG.
Alpha-fetoprotein is consistently produced by pure yolk-sac tumors, ~7'~8'27'3~ but also by mixed tumors with yolk-sac components and occasionally by embryonal carcinomas. ~9 Beta-HCG is produced by syncytiotrophoblastic giant cells, typically the main component of choriocarcinoma, but syncytiotrophoblastic giant cells can be detected independently in other components of mixed germ-cell tumors, including germinomas. This is illustrated by our Case 9, where syncytiotrophoblastic giant cells with expression of beta-HCG were found in the germinoma component of a mixed germ-cell tumor.
We are aware of only four other cases of primary intracranial germ-cell tumors with syncytiotrophoblastic giant cells. 13'18-2~ This variant may be clinically important; in a recent report, precocious puberty in a child was attributed to the presence of syncytiotrophoblastic giant cells in an otherwise typical germinoma. 19 Germcell tumors with elevation of both AFP and beta-HCG are commonly associated with the diagnosis of embryonal carcinomas. However, in the mixed germ-cell tumor in our Case 9, AFP production was restricted to the yolk-sac components and beta-HCG expression to syncytiotrophoblastic giant cells in the germinoma component. This illustrates that it is possible by immunohistochemical examination to localize the AFPand beta-HCG-producing tissue in particular components of a tumor.
A further argument in favor of the value of histological and immunohistochemical diagnosis lies in the observation that there are false-negative serum measurements. This may be due to the fact that the tumor cells produce the markers, but do not secrete them into the bloodstream, or simply because the tumors do not produce AFP or beta-HCG at all. 29 In our 14 cases, only three had demonstrable expression of tumor markers. In addition, elevated serum levels of AFP and beta-HCG can be found in conditions other than germcell tumors, such as associated with hepatocellular carcinoma or during pregnancyfl 4 All of the above-mentioned examples illustrate that the information given by histological diagnosis and immunohistochemical tests leads to better documented diagnosis than serum screening alone.
The presence of a sarcomatous component suggestive of early myoblastic differentiation within an immature teratoma in our Case 12 is of special interest. We are aware of only two previous cases of intracranial teratomas with a rhabdomyosarcomatous component. 8 '22 The presence of a sarcomatous component in teratomas leads to a poor prognosis. The patient of Glass and Culbertson s died 1 day postoperatively, our patient survived 4 months, and survival time reported in the case of Preissig, et al., 22 was 1 year. The same is reported for intragonadal examples of this rare entity. We thus can conclude that subtyping and biological behavior of intracranial germ-cell tumors are comparable to those of their gonadal counterparts. The more detailed histopathological classification of testicular germ-cell tumors 14 should therefore be applied to intracranial germcell tumors. Some reports indicate that biopsy may increase the risk of spinal metastasis in germinomas. 2s In our series of eight germinomas, seven were treated by primary microsurgical subtotal or total extirpation and postoperative radiotherapy. Only one case was diagnosed by a stereotaxic biopsy and was treated by radiotherapy only. Of the eight patients, only one (Case 1) developed spinal cord metastasis but he is still alive after 6 years.
Two patients died from local tumor recurrences 4 months and 5 years after operation. Of the 14 patients, 75 % have no evidence of recurrence during observation periods of 2 to 6 years. In the more heterogeneous groups of germ-cell tumors with mixed tumor components, two of three patients with highly malignant variants died 5 months and 2 years postoperatively; the third patient is living 3 years after the first operation but has a local recurrence and evidence of spinal cord metastasis. Of the three patients with mature teratomas, one died 5 years after surgery, while two others are living and well 3 and 4 years postoperatively. Only two of our patients underwent preoperative radiotherapy. Both died, one within 5 months and the other within 5 years. Tumors not responding to conservative therapy (consisting of shunting and preoperative radiotherapy) may have grown to a stage where a total surgical extirpation is unlikely and the prognosis therefore worsened. These results indicate that primary microsurgical inter-vention, if performed by an experienced neurosurgeon, leads not only to a biopsy-proven diagnosis and exact classification of primary intracranial germ-cell tumors, but also represents the most effective therapeutic approach.
